Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Direxion Daily Semiconductor Bull 3X Shares (SOXL) vs 22nd Century Group Inc (XXII) Price & Performance

Direxion Daily Semiconductor Bull 3X SharesTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Direxion Daily Semiconductor Bull 3X Shares vs 22nd Century Group Inc — how do they compare? Direxion Daily Semiconductor Bull 3X Shares trades at $139.65 (market cap $24.42B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Direxion Daily Semiconductor Bull 3X Shares is far larger — about 39281.3× 22nd Century Group Inc's market cap, and Direxion Daily Semiconductor Bull 3X Shares is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily Semiconductor Bull 3X Shares for 15 Days and 22nd Century Group Inc for 32 Days on average.

SOXLXXII
Market Cap
$24.42B$621.67K
Volume
100,232,38045,625
Sector
Leveraged / InverseConsumer Staples
52-Week High
$300.77$483.00
52-Week Low
$30.81$0.80
Typical Hold Time
15 Days32 Days
Enterprise Value
—-$3.69M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Direxion Daily Semiconductor Bull 3X Shares

SOXL, the Direxion Daily Semiconductor Bull 3X ETF, is trading at $139.3, down 12.34% in the last 24 hours amid semiconductor sector volatility. Technical indicators show a bearish overall signal with mixed moving averages and neutral oscillators. The fund's leveraged structure amplifies both gains and losses in the semiconductor sector, which faces conflicting signals from strong AI demand versus concerns about valuation and regulatory risks.

The outlook for SOXL remains highly volatile, with opportunities tied to sustained AI-driven semiconductor demand but significant risks from the fund's 3x leverage structure and sector-specific headwinds. Investors face amplified exposure to semiconductor stock fluctuations, requiring careful risk management given the current bearish technical setup and mixed market sentiment.

22nd Century Group Inc

22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.

While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SOXL
49% Buy51% Sell
Avg holding period · 15 Days
XXII
100% Buy0% Sell
Avg holding period · 32 Days

About Direxion Daily Semiconductor Bull 3X Shares

SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.

Read more on SOXL →

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII →